Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease
Medicine in Microecology
; 6 (no pagination), 2020.
Article
in English
| EMBASE | ID: covidwho-2257268
ABSTRACT
Fecal microbiota transplantation (FMT), as an emerging therapy, can be used to treat microbiota related diseases. Progresses in donor screening, washed microbiota preparation, microbiota delivery routes, clinical administrative strategies, and long-term safety are moving FMT forward. Increasing clinical studies, especially those randomized controlled trials about ulcerative colitis and pilot real-word studies about serious inflammatory bowel disease (IBD), have been conducted. This review presents the latest findings about the efficacy, safety and methodology of FMT in treating IBD.Copyright © 2020 The Authors
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Medicine in Microecology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS